Anna Bogaczewicz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna Bogaczewicz has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Tomasz Sobów
3 shared publicationsAnna Woźniacka
2 shared publicationsEwa Robak
2 shared publicationsJakub Ząbek
2 shared publicationsJan Kowalski
2 shared publications- Anna Woźniacka
Department of Dermatology and Venereology, Medical University of Lodz, 90-647 Lodz, Poland
1 shared publication
Latest Publications
- Open Access
- 30 June 2017
- Published by Medical Communications Sp. z.o.o. in Psychiatria i Psychologia Kliniczna
- Vol. 17 (2) , 111-114
Psychiatric adverse effects of chloroquine
Psychiatric adverse effects of chloroquine
- 30 June 2017
- Published by Medical Communications Sp. z.o.o. in Psychiatria i Psychologia Kliniczna
- Vol. 17 (2) , 111-114
Open AccessPsychiatric adverse effects of chloroquine
Psychiatric adverse effects of chloroquine
- 10 June 2016
- Published by Medical Communications Sp. z.o.o. in Psychiatria i Psychologia Kliniczna
- Vol. 16 (2) , 81-85
Funkcje poznawcze a autoprzeciwciała u chorych na toczeń rumieniowaty układowy
- 10 June 2016
- Published by Medical Communications Sp. z.o.o. in Psychiatria i Psychologia Kliniczna
- Vol. 16 (2) , 81-85
Funkcje poznawcze a autoprzeciwciała u chorych na toczeń rumieniowaty układowy
- Open Access
- 31 December 2015
- Published by Medical Communications Sp. z.o.o. in Psychiatria i Psychologia Kliniczna
- Vol. 15 (4) , 169-174
Badanie zależności pomiędzy funkcjami poznawczymi oraz stanem układu sercowo-naczyniowego u chorych na toczeń rumieniowaty układowy bez objawów neuropsychiatrycznych
The examination of the relationship between cognitive functions and cardiovascular condition in systemic lupus erythematosus patients without obvious neuropsych
- 31 December 2015
- Published by Medical Communications Sp. z.o.o. in Psychiatria i Psychologia Kliniczna
- Vol. 15 (4) , 169-174
Open AccessBadanie zależności pomiędzy funkcjami poznawczymi oraz stanem układu sercowo-naczyniowego u chorych na toczeń rumieniowaty układowy bez objawów neuropsychiatrycznych
The examination of the relationship between cognitive functions and cardiovascular condition in systemic lupus erythematosus patients without obvious neuropsych
- Open Access
- 30 July 2015
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 53 (3) , 131-138
Cambridge Neuropsychological Test Automated Battery in assessment of cognitive parameters in patients with systemic lupus erythematosus in relation to autoantibody profile
Objectives: To relate the cognitive parameters of systemic lupus erythematosus (SLE) patients in remission to their profile of autoantibodies. Material and methods: The study included 32 patients with SLE in remission, with mild disease activity as indicated by SELENA-SLEDAI < 6. For neuropsychological assessment, the Cambridge Neuropsychological Test Automated Battery (CANTAB) was applied, using motor screening (MOT), big little circle (BLC), paired associated learning (PAL), stockings of Cambridge (SOC), and graded naming tests (GNT). Detection of autoantibodies against dsDNA, nucleosome (aNuc), Sm, and anticardiolipin (aCL: IgG and IgM) was performed with immunoassays. Results: The SLE patients demonstrated standard scores below norms, matched according to age and gender, in the following tests: GNT (–0.87 ±0.85), SOC PSMM (–0.47 ±0.97), PAL (–1.88 ±3.58), and BLC (–0.31 ±1.90). GNT scores under –0.5 were found significantly more frequently in SLE patients, seen in roughly 66% of test subjects. Values for PAL and mean subsequent thinking time of stockings of Cambridge (SOC MSTT) were found to be lower than –0.5 in approximately half of the patients. Mean error of motor screening (MOT ME) was found to negatively correlate with mean latency of motor screening (MOT ML) (r = –0.55). PAL significantly correlated with SOC MSTT (r = 0.38) and with GNT (r = 0.36). Anti-dsDNA antibody level correlated negatively with MOT ME (r = –0.46). Anti-Nuc antibodies correlated with MOT ML (r = 0.41) but negatively correlated with MOT ME (r = –0.58). The levels of anti-Sm, anti-CL IgM and IgG did not correlate significantly with the outcomes of CANTAB. The age of the patients correlated negatively with MOT ME (r = –0.36), positively with BLC (r = 0.53) and negatively with SOC MSTT (r = –0.43). The level of anti-Nuc antibodies correlated with anti-dsDNA level (r = 0.62) and of anti-CL IgM with anti-Sm (r = 0.39) and anti-CL IgG (r = 0.87). Conclusions: CANTAB reveals a decrease in selected cognitive functions in patients with SLE. ACL IgG and anti-dsDNA antibodies indicated SLE patients prone to develop a decrease in cognitive functions.
- 30 July 2015
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 53 (3) , 131-138
Open AccessCambridge Neuropsychological Test Automated Battery in assessment of cognitive parameters in patients with systemic lupus erythematosus in relation to autoantibody profile
Objectives: To relate the cognitive parameters of systemic lupus erythematosus (SLE) patients in remission to their profile of autoantibodies. Material and methods: The study included 32 patients with SLE in remission, with mild disease activity as indicated by SELENA-SLEDAI < 6. For neuropsychological assessment, the Cambridge Neuropsychological Test Automated Battery (CANTAB) was applied, using motor screening (MOT), big little circle (BLC), paired associated learning (PAL), stockings of Cambridge (SOC), and graded naming tests (GNT). Detection of autoantibodies against dsDNA, nucleosome (aNuc), Sm, and anticardiolipin (aCL: IgG and IgM) was performed with immunoassays. Results: The SLE patients demonstrated standard scores below norms, matched according to age and gender, in the following tests: GNT (–0.87 ±0.85), SOC PSMM (–0.47 ±0.97), PAL (–1.88 ±3.58), and BLC (–0.31 ±1.90). GNT scores under –0.5 were found significantly more frequently in SLE patients, seen in roughly 66% of test subjects. Values for PAL and mean subsequent thinking time of stockings of Cambridge (SOC MSTT) were found to be lower than –0.5 in approximately half of the patients. Mean error of motor screening (MOT ME) was found to negatively correlate with mean latency of motor screening (MOT ML) (r = –0.55). PAL significantly correlated with SOC MSTT (r = 0.38) and with GNT (r = 0.36). Anti-dsDNA antibody level correlated negatively with MOT ME (r = –0.46). Anti-Nuc antibodies correlated with MOT ML (r = 0.41) but negatively correlated with MOT ME (r = –0.58). The levels of anti-Sm, anti-CL IgM and IgG did not correlate significantly with the outcomes of CANTAB. The age of the patients correlated negatively with MOT ME (r = –0.36), positively with BLC (r = 0.53) and negatively with SOC MSTT (r = –0.43). The level of anti-Nuc antibodies correlated with anti-dsDNA level (r = 0.62) and of anti-CL IgM with anti-Sm (r = 0.39) and anti-CL IgG (r = 0.87). Conclusions: CANTAB reveals a decrease in selected cognitive functions in patients with SLE. ACL IgG and anti-dsDNA antibodies indicated SLE patients prone to develop a decrease in cognitive functions.